-
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Post on 1/12/21
-
Vedanta Biosciences Announces $25 Million Investment from Pfizer
Post on 1/12/21
-
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
Post on 1/12/21
-
Bristol Myers Squibb Announces $2 Billion Incremental Share Repurchase Authorization
Post on 1/11/21
-
Ashikari Breast Center Joins Northwell Health Physician Partners
Post on 1/11/21
-
My Best Biotech Stock for 2021
Post on 1/11/21
-
Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021
Post on 1/11/21
-
Carrum Health Raises $40M in Series A Funding
Post on 1/8/21
-
Columbia Care Announces C$130 Million Bought Deal Public Offering
Post on 1/8/21
-
Pfizer Stock: A Top Bet for 2021?
Post on 1/8/21
-
SWORD Health Becomes World’s Fastest Growing Virtual Musculoskeletal Solution
Post on 1/7/21
-
Biohaven Acquires Kleo Pharmaceuticals
Post on 1/7/21
-
Aquestive Therapeutics Provides Business Update
Post on 1/7/21
-
Pacira Reports Record Revenue for 2020 of $429.6 Million
Post on 1/7/21
-
Is Pfizer Stock a Buy?
Post on 1/7/21
-
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Post on 1/6/21
-
Could Johnson & Johnson Be a Millionaire-Maker Stock?
Post on 1/6/21
-
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
Post on 1/6/21
-
Pfizer Launches First Major Rebranding in Over 70 Years
Post on 1/6/21
-
ProPhase Labs Offers $5.5 Million of Common Stock and Warrants
Post on 1/5/21
-
Quest Diagnostics: A COVID-19 Beneficiary
Post on 1/5/21
-
ADMA Biologics: A Perfect Storm
Post on 1/5/21
-
Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%
Post on 1/5/21
-
Flowonix Medical and SWK Holdings Closes $33M Financing
Post on 1/4/21
-
Dun & Bradstreet - Increasingly Appealing
Post on 1/4/21
New York
